Health

Ascentage Pharma Announces a New Drug Application for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Recommended Priority Review Designation by CDE of China NMPA

ROCKVILLE, Md. and SUZHOU, China, Nov. 17, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that a New Drug Applica...

2024-11-17 22:24 1452

World-Class Scientists Gather at Tencent 2024 WE Summit in Chengdu to Share Cutting-Edge Discoveries

Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at theTencent WE Summit in Chengdu. SHENZHEN, China, Nov. 15, 2024 /PRNewswire/ -- On November 3, the 12th Annual Tencent WE Summit took place at the Chengdu Science Fiction Mu...

2024-11-15 22:59 2437

International Cancer Organizations Present Collaborative Work During Oncology Event in China

The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO). XI'AN, China, Nov. 15, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network...

2024-11-15 09:04 1499

SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 15, 2024 /PRNewswire/ -- SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGM...

2024-11-14 23:45 834

Cigna Healthcare Hong Kong announced as Title Sponsor for HYROX's first Asian Championships

The Cigna Healthcare HYROX Open Asian Championships will bring over 6,300 fitness enthusiasts to Hong Kong HONG KONG, Nov. 14, 2024 /PRNewswire/ -- Cigna Healthcare Hong Kong, a leading health benefits provider, has announced its title sponsorship of the Cigna Healthcare HYROX Open Asian Cha...

2024-11-14 18:00 1838

Ubiquity Sprouting Corporation Unveils Prototype for Revolutionary Germinated Plant Milk Production System

TAIPEI, Nov. 14, 2024 /PRNewswire/ -- Ubiquity Sprouting Corporation has achieved a major milestone in the plant-based milk industry, completing the prototype of its innovative germinated plant milk production equipment. This cutting-edge technology, designed to work seamlessly with Ubiquity's s...

2024-11-14 15:57 1250

Lilly expands R&D footprint in Singapore with SGD$42 million investment in new Digital Health Innovation Hub

Lilly to drive next-generation AI-powered digital health technology research in Singapore SINGAPORE, Nov. 14, 2024 /PRNewswire/ -- Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), today announced the e...

2024-11-14 15:10 1383

Sun Life Survey Reveals Hidden Financial and Mental Health Impacts of Type 2 Diabetes

* One third (33%) of those living with diabetes report a 'severe' or 'significant' financial impact on their lives, with 82% unable to consistently afford the right care.  * 67% of non-diabetics are either 'very concerned' or 'concerned' about the financial burden that would result from a typ...

2024-11-14 14:06 927

Witsbb Makes Its Appearance at the 2024 CIIE! Focusing on Global Sensitive Baby Health, Sharing China's Opportunities

SYDNEY, Nov. 13, 2024 /PRNewswire/ -- From November 5 to 10, the 7th China International Import Expo (CIIE) was held inShanghai, with 152 countries, regions, and international organizations participating in the national and corporate exhibitions. Witsbb, a leading brand in "hypoallergenic" infant...

2024-11-14 10:29 1483

Suvoda Awarded US Patent for its eCOA Software Architecture

Low-code, no-code approach accelerates eCOA questionnaire design and deployment, taking questionnaire creation, licensing, and localization off the critical path  PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ -- Suvoda, a global clinical trial technology company specializing in complex studies in the...

2024-11-14 09:00 1221

Breakthrough Research Presented in Scientific Reports Demonstrates How Gene-Edited Microbes Offer a New Source of Nitrogen to Farmers

Findings are the first, peer-reviewed evidence of gene-edited microbes supplying a material proportion of corn farmers' nitrogen in commercial production  BERKELEY, Calif., Nov. 14, 2024 /PRNewswire/ -- Peer-reviewed research published today in Scientific Reports describes a new technology ...

2024-11-14 05:42 1245

QNET Product User Sets World Record: 51-Year-Old Achieves 20 Consecutive Back Handsprings

Debnath credits QNET's Amezcua Chi Pendant 4 for supporting his mind-body balance in pursuit of a Guinness World Record HONG KONG, Nov. 14, 2024 /PRNewswire/ -- QNET, a global wellness and lifestyle company, proudly celebrates the remarkable achievement ofAnup Debnath , a 51-year-old fitness enth...

2024-11-14 01:18 1810

Think You've Been Harmed By Products Containing Talc? You May Have The Right To Vote On The Plans Of Reorganization Filed By Imerys Talc And/Or Cyprus Mines That Determine How Talc Personal Injury Claims Against These Debtors Are Treated

Vote on the Plans by December 16, 2024 NEW YORK, Nov. 13, 2024 /PRNewswire/ -- The following statement is being issued by Kroll Restructuring Administration LLC regarding the Imerys Talc and Cyprus Mines Bankruptcy Cases. If you have a Talc Personal Injury Claim, your rights are affected by an ...

2024-11-13 23:30 1777

New Evidence-Based Information from NCCN Offers Tangible and Moral Support for People Trying to Quit Smoking

New NCCN Guidelines for Patients: Quitting Smoking showcases attainable and uplifting options that empower people with cancer to achieve better health outcomes. PLYMOUTH MEETING, Pa., Nov. 13, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer ...

2024-11-13 21:06 1402

Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

BRADENTON, Fla. and HOUSTON, Nov. 13, 2024 /PRNewswire/ -- Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell reprogramming, immune modulation, and drug delivery, is excited to announce its official launch. The com...

2024-11-13 20:30 1183

NaoTrac Robot Pioneers Robotic Neurosurgery in Bolivia with Successful Brain Tumor Biopsies

HSINCHU, Nov. 13, 2024 /PRNewswire/ -- On November 5, 2024, Bolivia marked a historic moment in neurosurgery at Hospital Arcoiris, where two successful brain tumor biopsy surgeries were conducted using NaoTrac, the world's first autonomous surgical navigation robot. These groundbreaking surgeries...

2024-11-13 20:10 1609

Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology

MELBOURNE, Australia and BERLIN, Germany, Nov. 13, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a technology collaboration and licence agreement withBerlin -based Eckert & Ziegler SE (EZAG) for the use of EZAG's cyclotro...

2024-11-13 16:18 1467

NEL Animal Medical Foundation of Korea, Successfully Concludes Seminar for Nong Lam University Scholarship Recipients

HO CHI MINH CITY, Vietnam, Nov. 13, 2024 /PRNewswire/ -- The NEL Animal Medical Foundation of Korea announced that the seminar and scholarship award ceremony held at Nong Lam University onNovember 2nd was successfully concluded.

2024-11-13 16:17 1444

Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners

Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON, Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners o...

2024-11-13 16:00 1090

Musim Mas Achieves a Top 5 Rank in the Global Child Forum Benchmark 2024

SINGAPORE, Nov. 13, 2024 /PRNewswire/ -- Musim Mas Group reached a significant milestone in the State of Children's Rights and Business 2024 Global Benchmark by Global Child Forum, achieving anoverall score of 9.3 out of 10, placing the Group in the top five of companies globally

2024-11-13 14:38 1347
123456 ... 580